logo-loader
viewLocation Sciences Group PLC

Location Sciences - Covid-19 Update

RNS Number : 2040H
Location Sciences Group PLC
23 March 2020
 

23 March 2020

 

Location Sciences Group PLC
("Location Sciences" or the "Company")

 

Covid-19 Update

 

Given the current and rapidly changing developments regarding COVID-19, Location Sciences (AIM: LSAI) provides the following update.  

Ways of working

We are a virtual business, operating across four locations globally. All of our systems are in the cloud, with our normal day involving Slack stand ups and Zoom conference calls. We have all been able to adjust to working from home very easily.

Business impact

We are still very small and a large part of our revenues are repeatable licence deals. We are also heavily H2, and specifically Q4, weighted in our forecasts and business plans to take into account seasonal spikes in advertising. The market has, of course, shifted and we are living in uncertain times. In addition, as we work with location advertisers, there will be campaigns that are postponed to later dates. However, we are already seeing new campaigns being launched - for example by companies operating in the pharmaceutical sector. We continue to support our global clients and are continuing to sign new customers up.

R&D

We are an early stage business still in the research and development stage of our product. In many ways, this time allows us to invest in the important engineering work we are undertaking. We are launching an updated version of our platform at the end of April 2020. This will give our customers a clearer picture of how to obtain better value from their location spend and how to drive better performance. This will be needed in the months ahead, as companies look for a competitive edge.

Data for good

As a location data business, with billions of location events, we are exploring how we can use this data (and our data science skills) for good, or wider initiatives we would like to help wherever we can. 

EGM Attendance

If you wish to attend the Company's General Meeting convened for 11.00 am on 26 March 2020 via webinar, please register in advance by following this link: https://locationsciences.zoom.us/webinar/register/WN_vNzqXAu9TZmALuHZfvwo4g. After registering, you will receive a confirmation email containing instructions on how to join.

Shareholders will not be able to vote via the webinar, so all shareholders wishing to attend on this basis must vote prior to the General Meeting by submitting a proxy vote by no later than 11.00 a.m. on 24 March 2020. Details of how to appoint a proxy are set out in the Company's circular to shareholders published on 9 March 2020 ("Circular") and available from the Company's website at https://www.locationsciencesgroup.ai/wp-content/uploads/2020/03/March-2020-Circular-and-Notice-of-General-Meeting.pdf

The General Meeting is being held to approve, amongst other things, the Resolutions related to the Company's Placing announced on 6 March 2020.

Mark Slade, Chief Executive Officer, commented "I understand that in these challenging times, communication is paramount. With that in mind, I wanted to share this update on our business operations and reassure our shareholders that their business remains on track to deliver value in 2020".

Terms used in this announcement but not otherwise defined have the meanings given to them in the Circular.

 

For further information please contact: 

 

Location Sciences Group PLC

via Milk and Honey PR

Mark Slade, Chief Executive Officer

 

David Rae, Chief Financial Officer

 

 

 

Shore Capital (Nomad and Joint Broker)

Tel: +44 (0)20 7408 4090

Tom Griffiths

 

David Coaten

 

 

 

Peterhouse Capital (Joint Broker)

Charles Goodfellow

Eran Zucker

Tel: +44 (0) 20 7220 9791

 

 

 

 

Milk & Honey PR

 Tel: +44 (0)20 3637 7310

Kirsty Leighton

 

Jessica Ballinger

 

 

The person making this notification on behalf of the Company is David Rae, Chief Financial Officer of the Company.

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
UPDKKNBPDBKDANB

Quick facts: Location Sciences Group PLC

Price: 0.54

Market: LSE
Market Cap: £2.88 m
Follow

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Location Sciences Group releases state of privacy and...

Location Sciences Group PLC (LON:LSAI) Chief Business Officer Jason Smith tells Proactive the AIM-listed company which provides verification and analytics services for location data, has released its state of privacy and location marketing report.  Smith says the report is in response to...

on 23/1/20